Randall Stanicky is the Chief Financial Officer (CFO) at Click Therapeutics. Prior to joining Click Therapeutics, he spent more than 20 years on Wall Street as a top-ranked equity analyst where he was a regular speaker at conferences and events both domestically and internationally. Most recently he served as Managing Director, Global Equity Research at RBC Capital Markets where he was ranked number 2 by Institutional Investor within the Specialty Pharmaceuticals sector. His coverage also included the large cap pharmaceutical sector and he led the cross-sector build-out of the firm's research efforts in Digital Health and regularly authored reports on the leading themes and debates within healthcare. Mr. Stanicky spent the majority of his Wall Street career at Goldman Sachs in a similar capacity covering several sectors across the healthcare space. He is also a Board member and Head of the Audit Committee for the Children's Tumor Foundation and previously sat on the Board of Directors of TherapeuticsMD (NASDAQ: TXMD), a women’s health focused pharmaceutical company.
Follow on: